[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, KAT2A is indeed involved in Acute myeloid leukemia (AML). Document [0] mentions that inhibition of KAT2A was able to suppress the growth of AML cells. Document [2] also states that KAT2A is a vulnerability in at least some forms of AML. Additionally, Document [4] highlights KAT2A as a candidate for downstream study in AML. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]